Treatment as Prevention¨

Model suggests HIV vaccine still has key role in ending AIDS

Even a modestly effective HIV vaccine would likely be cost-effective and could make a major contribution to a sustainable response to the global HIV/AIDS epidemic, especially in combination with the scale-up of other interventions including prompt initiation of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP), according to a report in the January 5 edition of

Model suggests HIV vaccine still has key role in ending AIDS Read More »

World-renowned AIDS experts from B.C. to help Indiana fight HIV epidemic in rural county

VANCOUVER – World-renowned HIV experts from British Columbia are stepping in to help control a massive outbreak of the disease in rural Indiana. The B.C. Centre for Excellence in HIV/AIDS is partnering with Indiana University’s school of medicine in an effort to stymie an epidemic in Scott County where 184 people have tested positive for

World-renowned AIDS experts from B.C. to help Indiana fight HIV epidemic in rural county Read More »

Indiana University and BC experts team up to control rural HIV crisis

VANCOUVER – World-renowned HIV experts from British Columbia are stepping up to help control a massive outbreak of the disease in rural Indiana. The BC Centre for Excellence in HIV/AIDS is partnering with the Indiana University School of Medicine in an effort to stymie an epidemic in Scott County, Ind., where 184 people have tested

Indiana University and BC experts team up to control rural HIV crisis Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025